Search

Your search keyword '"Ziagkos, Dimitris"' showing total 13 results
Start Over Author "Ziagkos, Dimitris"
13 results on '"Ziagkos, Dimitris"'

1. Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion

Author

Garderet, Laurent, Ziagkos, Dimitris, van Biezen, Anja, Iacobelli, Simona, Finke, Jürgen, Maertens, Johan, Volin, Liisa, Ljungman, Per, Chevallier, Patrice, Passweg, Jakob, Schaap, Nicolaas, Beelen, Dietrich, Nagler, Arnon, Blaise, Didier, Poiré, Xavier, Yakoub-Agha, Ibrahim, Lenhoff, Stig, Craddock, Charles, Schots, Rik, Rambaldi, Alessandro, Sanz, Jaime, Jindra, Pavel, Mufti, Ghulam J., Robin, Marie, and Kröger, Nicolaus

Published
2018
Full Text
View/download PDF

2. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Author

van Gelder, Michel, Ziagkos, Dimitris, de Wreede, Liesbeth, van Biezen, Anja, Dreger, Peter, Gramatzki, Martin, Stelljes, Matthias, Andersen, Niels Smedegaard, Schaap, Nicolaas, Vitek, Antonin, Beelen, Dietrich, Lindström, Vesa, Finke, Jürgen, Passweg, Jacob, Eder, Matthias, Machaczka, Maciej, Delgado, Julio, Krüger, William, Raida, Luděk, Socié, Gerard, Jindra, Pavel, Afanasyev, Boris, Wagner, Eva, Chalandon, Yves, Henseler, Anja, Schoenland, Stefan, Kröger, Nicolaus, and Schetelig, Johannes

Published
2017
Full Text
View/download PDF

3. Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Author

Heidenreich, Silke, Ziagkos, Dimitris, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Jürgen, Platzbecker, Uwe, Niederwieser, Dietger, Einsele, Hermann, Bethge, Wolfgang, Schleuning, Michael, Beelen, Dietrich W., Tischer, Johanna, Nagler, Arnon, Glass, Bertram, Maertens, Johan, Yáñez, Lucrecia, Beguin, Yves, Sill, Heinz, Scheid, Christof, Stelljes, Matthias, Ganser, Arnold, Zachée, Pierre, Selleslag, Dominik, de Witte, Theo, Robin, Marie, and Kröger, Nicolaus

Published
2017
Full Text
View/download PDF

4. A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Author

Cremers, Eline M.P., primary, de Witte, Theo, additional, de Wreede, Liesbeth, additional, Eikema, Diderik-Jan, additional, Koster, Linda, additional, van Biezen, Anja, additional, Finke, Jürgen, additional, Socié, Gerard, additional, Beelen, Dietrich, additional, Maertens, Johan, additional, Nagler, Arnon, additional, Kobbe, Guido, additional, Ziagkos, Dimitris, additional, Itälä-Remes, Maija, additional, Gedde-Dahl, Tobias, additional, Sierra, Jorge, additional, Niederwieser, Dietger, additional, Ljungman, Per, additional, Beguin, Yves, additional, Ozkurt, Zubeyde Nur, additional, Anagnostopoulos, Achilles, additional, Jindra, Pavel, additional, Robin, Marie, additional, and Kröger, Nicolaus, additional

Published
2019
Full Text
View/download PDF

5. Relapse Risk Score after Allogeneic Stem Cell Transplantation for MDS Patients. an EBMT Study from the MDS Subcommittee of Chronic Malignancies Working Party (CMWP)

Author

Kröger, Nicolaus, primary, Putter, Hein, additional, De Wreede, Liesbeth, additional, van Biezen, Anja, additional, Ziagkos, Dimitris, additional, Volin, Liisa, additional, Maertens, Johan, additional, Finke, Jürgen, additional, Ljungman, Per T., additional, Russell, Nigel H., additional, Yakoub-Agha, Ibrahim, additional, Schaap, Michel, additional, Craddock, Charles, additional, Mufti, Ghulam J, additional, Chevallier, Patrice, additional, Passweg, Jakob R, additional, Milpied, Noel, additional, Blaise, Didier, additional, Bourhis, Jean-Henri, additional, Gedde-Dahl, Tobias, additional, Espiga, Carlos Richard, additional, Cornelissen, Jan J., additional, Göhring, Gudrun, additional, Schetelig, Johannes, additional, de Witte, Theo, additional, and Robin, Marie, additional

Published
2016
Full Text
View/download PDF

6. Outcomes of Mismatched Related Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Author

van Gorkom, Gwendolyn, primary, van Gelder, Michel, additional, Ziagkos, Dimitris, additional, Blok, Henric-Jan, additional, van Lint, Maria Teresa, additional, Koc, Yener, additional, Ciceri, Fabio, additional, Beelen, Dietrich W., additional, Chevallier, Patrice, additional, Selleslag, Dominik, additional, Blaise, Didier, additional, Foà, Roberto, additional, Corradini, Paolo, additional, Castagna, Luca, additional, Moreno, Carol, additional, Solano, Carlos, additional, Müller, Lutz P., additional, Tischer, Johanna, additional, Hilgendorf, Inken, additional, Hallek, Michael, additional, Bittenbring, Joerg Thomas, additional, Theobald, Matthias, additional, Schetelig, Johannes, additional, and Kröger, Nicolaus, additional

Published
2016
Full Text
View/download PDF

7. Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Author

van Gelder, Michel, primary, Ziagkos, Dimitris, additional, de Wreede, Liesbeth C, additional, van Biezen, Anja, additional, Dreger, Peter, additional, Gramatzki, Martin, additional, Stelljes, Matthias, additional, Smedegaard Andersen, Niels, additional, Schaap, Nicolaas PM, additional, Vitek, Antonin, additional, Beelen, Dietrich, additional, Volin, Liisa, additional, Finke, Jürgen, additional, Passweg, Jakob R, additional, Ganser, Arnold, additional, Machaczka, Maciej J, additional, Delgado, Julio, additional, Krüger, William, additional, Faber, Edgar, additional, Socie, Gerard, additional, Jindra, Pavel, additional, Afanasyev, Boris V, additional, Theobald, Matthias, additional, Chalandon, Yves, additional, Henseler, Anja, additional, Schoenland, Stefan O., additional, Nicolaus, Kroger, additional, and Schetelig, Johannes, additional

Published
2016
Full Text
View/download PDF

8. Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT

Author

Velardi, Andrea, primary, Ruggeri, Loredana, additional, Ziagkos, Dimitris, additional, van Biezen, Anja, additional, Merluzzi, Mara, additional, Bondanza, Attilio, additional, Bootsman, Nathasja, additional, Massei, Maria Speranza, additional, Amico, Lucia, additional, Piccinelli, Sara, additional, Noviello, Maddalena, additional, Ciceri, Fabio, additional, Klingebiel, Thomas, additional, Koc, Yener, additional, Veelken, Hendrik, additional, Locatelli, Franco, additional, Arcese, William, additional, Gruhn, Bernd, additional, Salvi, Flavia, additional, Bonini, Chiara, additional, and van Rood, Jon J., additional

Published
2016
Full Text
View/download PDF

9. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

Author

Cook, Gordon, primary, Iacobelli, Simona, additional, van Biezen, Anja, additional, Ziagkos, Dimitris, additional, LeBlond, Veronique, additional, Abraham, Julie, additional, McQuaker, Grant, additional, Schoenland, Stefan, additional, Rambaldi, Alessandro, additional, Halaburda, Kazimierz, additional, Rovira, Maria, additional, Sica, Simona, additional, Byrne, Jenny, additional, Sanz, Ramon Garcia, additional, Nagler, Arnon, additional, van de Donk, Niels W.C.J., additional, Sinisalo, Marjatta, additional, Cook, Mark, additional, Kröger, Nicolaus, additional, De Witte, Theo, additional, Morris, Curly, additional, and Garderet, Laurant, additional

Published
2016
Full Text
View/download PDF

10. Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Author

Heidenreich, Silke, primary, Ziagkos, Dimitris, additional, van Biezen, Anja, additional, Finke, Jürgen, additional, Platzbecker, Uwe, additional, Niederwieser, Dietger, additional, Einsele, Hermann, additional, Bethge, Wolfgang A, additional, Schleuning, Michael, additional, Beelen, Dietrich W., additional, Tischer, Johanna, additional, Nagler, Arnon, additional, Glass, Bertram, additional, Maertens, Johan, additional, Richard, Carlos, additional, Beguin, Yves, additional, Sill, Heinz, additional, de Witte, Theo, additional, Robin, Marie, additional, and Kroeger, Nicolaus, additional

Published
2015
Full Text
View/download PDF

11. An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT

Author

Bondanza, Attilio, primary, Ruggeri, Loredana, additional, Ziagkos, Dimitris, additional, Bonini, Chiara, additional, Chabannon, Christian, additional, Bootsman, Natalia, additional, Knol-Bout, Cora, additional, De Wreede, Liesbeth, additional, Noviello, Maddalena, additional, Crucitti, Lara, additional, Vago, Luca, additional, Carotti, Alessandra, additional, Terenzi, Adelmo, additional, Merluzzi, Mara, additional, Massei, Maria Speranza, additional, Amico, Lucia, additional, Piccinelli, Sara, additional, Veelken, Joan Hendrik, additional, Koc, Yener, additional, Bader, Peter, additional, Gruhn, Bernd, additional, Locatelli, Franco, additional, Ciceri, Fabio, additional, Toubert, Antoine, additional, and Velardi, Andrea, additional

Published
2015
Full Text
View/download PDF

12. Allogeneic hematopoietic stem cell transplantation using HLA-compatible donors in younger high cytogenetic risk CLL patients results in very high long-term progression-free survival and may therefore favorably compete with sequential targeted therapy

Author

Gelder, Michel, Ziagkos, Dimitris, Wreede, Liesbeth, Biezen, Anja, Dreger, Peter, Gramatzki, Martin, Stelljes, Matthias, Andersen, Niels Smedegaard, Nicolaas Schaap, Vitek, Antonin, Beelen, Dietrich, Volin, Liisa, Finke, Juergen, Passweg, Jacob, Eder, Matthias, Machaczka, Maciej, Delgado, Julio, Krueger, William, Raida, Ludek, Socie, Gerard, Jindra, Pavel, Afanasyev, Boris, Wagner, Eva, Chalandon, Yves, Henseler, Anja, Schoenland, Stefan, Kroeger, Nicolaus, and Schetelig, Johannes

13. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

Author

Cook G, Iacobelli S, van Biezen A, Ziagkos D, LeBlond V, Abraham J, McQuaker G, Schoenland S, Rambaldi A, Halaburda K, Rovira M, Sica S, Byrne J, Sanz RG, Nagler A, van de Donk NW, Sinisalo M, Cook M, Kröger N, De Witte T, Morris C, and Garderet L

Subjects
Adult, Aged, Disease Progression, Female, Graft Rejection, Graft Survival, Humans, Male, Middle Aged, POEMS Syndrome diagnosis, POEMS Syndrome mortality, Retrospective Studies, Survival Analysis, Time-to-Treatment, Transplantation Conditioning, Transplantation, Autologous, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Hematopoietic Stem Cell Transplantation methods, POEMS Syndrome therapy
Abstract

POEMS syndrome is a rare para-neoplastic syndrome secondary to a plasma cell dyscrasia. Effective treatment can control the disease-related symptom complex. We describe the clinical outcome of autologous stem cell transplantation for patients with POEMS syndrome, determining the impact of patient- and disease-specific factors on prognosis. One hundred and twenty-seven patients underwent an autologous stem cell transplantation between 1997-2010 with a median age of 50 years (range 26-69 years). Median time from diagnosis to autologous stem cell transplantation was 7.5 months with 32% of patients receiving an autologous stem cell transplantation more than 12 months from diagnosis. Engraftment was seen in 97% patients and engraftment syndrome was documented in 23% of autologous stem cell transplantation recipients. Hematologic response was characterized as complete response in 48.5%, partial response in 20.8%, less than partial repsonse in 30.7%. With a median follow up of 48 months (95%CI: 38.3, 58.6), 90% of patients are alive and 16.5% of patients have progressed. The 1-year non-relapse mortality was 3.3%. The 3-year probabilities of progression-free survival and overall survival are 84% and 94%, respectively, with 5-year probabilities of progression-free survival and overall survival of 74% and 89%. In a cohort of graft recipients, detailed organ-specific symptom response demonstrated clear symptom benefit after autologous stem cell transplantation especially in relation to neurological symptom control. The data analyzed in this study demonstrate the clinical utility of autologous stem cell transplantation for patients with POEMS syndrome., (Copyright© Ferrata Storti Foundation.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results